Results 161 to 170 of about 7,404 (210)

Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea. [PDF]

Cancer Res Treat, 2022
Park B, Kim D, Kim J, Lee BY, Yoon J, Kim SW.   +5 more
europepmc   +1 more source

Validation of adopting vaginal natural orifice transluminal endoscopic surgery for risk-reducing salpingo-oophorectomy for women with germline BRCA1/2 pathogenic variants analysis from conventional procedure. [PDF]

Obstet Gynecol Sci
Nomura H, Abe A, Fusegi A, Kamata M, Ueki A, Kanao H.   +5 more
europepmc   +1 more source

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66. [PDF]

BJOG, 2022
Manchanda R, Gaba F, Talaulikar V, Pundir J, Gessler S, Davies M, Menon U, Royal College of Obstetricians and Gynaecologists.   +7 more
europepmc   +1 more source

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers. [PDF]

Gynecol Oncol, 2021
Cowan R, Nobre SP, Pradhan N, Yasukawa M, Zhou QC, Iasonos A, Soslow RA, Arnold AG, Trottier M, Catchings A, Roche KL, Gardner G, Robson M, Abu Rustum NR, Aghajanian C, Cadoo K.   +15 more
europepmc   +1 more source

Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant. [PDF]

Sci Rep
Choi YJ, Park Y, Park B, Chae H, Jung SY, Ryu KH, Lim MC, Park SJ, Chang YJ, Kong SY.   +9 more
europepmc   +1 more source

The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. [PDF]

J Gynecol Oncol
Lee YJ, Kim JH, Kim YJ, Chang YJ, Kong SY, Yoo CW, Lee DO, Seo SS, Kang S, Park SY, Lim MC.   +10 more
europepmc   +1 more source

Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine. [PDF]

Gynecol Oncol
Metcalf CA, Page CE, Stocker BOS, Johnson RL, Duffy KA, Sammel MD, Loughead J, Epperson CN.   +7 more
europepmc   +1 more source

Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy. [PDF]

Healthcare (Basel)
Ali AM, Al-Dossary SA, Laranjeira C, Amer F, Hallit S, Alkhamees AA, Aljubilah AF, Aljaberi MA, Alzeiby EA, Fadlalmola HA, Pakai A, Khatatbeh H.   +11 more
europepmc   +1 more source

BRCA in breast cancer: ESMO Clinical Practice Guidelines [PDF]

, 2017
Balmaña, J., Castiglione, M., Diez, O., Rubio, I.   +3 more
core  

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation. [PDF]

J Breast Cancer, 2020
Jung SM, Ryu JM, Park HS, Park JS, Kang E, Lee S, Lee HB, Youn HJ, Yoo TK, Kim J, Lee JE, Han SA, Kim D, Kim SW, Korean Hereditary Breast Cancer Study Group.   +14 more
europepmc   +1 more source